S

Svas Biosana SpA
MIL:SVS

Watchlist Manager
Svas Biosana SpA
MIL:SVS
Watchlist
Price: 8.16 EUR Market Closed
Market Cap: €43.5m

Svas Biosana SpA
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Svas Biosana SpA
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
S
Svas Biosana SpA
MIL:SVS
EPS (Diluted)
€1
CAGR 3-Years
24%
CAGR 5-Years
20%
CAGR 10-Years
N/A
I
Ivision Tech SpA
MIL:IVN
EPS (Diluted)
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Svas Biosana SpA
Glance View

Market Cap
43.5m EUR
Industry
Health Care

Svas Biosana SpA distributes medical appliances. The company is headquartered in Somma Vesuviana, Napoli and currently employs 367 full-time employees. The company went IPO on 2021-12-09. The firm consists of four divisions namely: Farmex division, manufactures range of gauze and cotton made products; Medical division, provides suction line, infusion line, and custom packs; Svas division, provides own brand products, specialities, galenic solutions and disposables; and Harvest division, provides electromedical equipments, after-sales technical services. The firm is the subsidiary of Svas group. Test Data.

SVS Intrinsic Value
14.82 EUR
Undervaluation 45%
Intrinsic Value
Price
S

See Also

What is Svas Biosana SpA's EPS (Diluted)?
EPS (Diluted)
1.1 EUR

Based on the financial report for Dec 31, 2024, Svas Biosana SpA's EPS (Diluted) amounts to 1.1 EUR.

What is Svas Biosana SpA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
20%

Over the last year, the EPS (Diluted) growth was 16%. The average annual EPS (Diluted) growth rates for Svas Biosana SpA have been 24% over the past three years , 20% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett